Neurogene Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
NGNE Nasdaq 2830 www.neurogene.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Neurogene Inc.

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Aug 4th, 2026 2:01 pm
Neurogene Inc. Announces Pricing of $125 Million Public Offering - Jul 1st, 2026 5:00 am
Neurogene Inc. Announces Proposed Public Offering - Jun 30th, 2026 2:01 pm
We Think Neurogene (NASDAQ:NGNE) Can Afford To Drive Business Growth - May 5th, 2026 5:37 am
Neurogene: Q4 Earnings Snapshot - Mar 24th, 2026 5:46 am
Neurogene CEO Details NGN-401 Rett Trial, FDA Alignment, and Key 2026 Catalysts at Conference - Mar 21st, 2026 1:02 am
Block upgraded, Duolingo downgraded: Wall Street's top analyst calls - Feb 27th, 2026 7:50 am
Here Are Friday’s Top Wall Street Analyst Research Calls: Block, Costco, Dollar Tree, Duolingo, Palantir Technologies, Southwest Airlines, Synopsis, Warner Bros. Discovery, and More - Feb 27th, 2026 5:59 am
Neurogene Maps NGN-401 Pivotal Rett Timeline, Mid-2026 Data Update at Guggenheim Summit - Feb 14th, 2026 7:05 am
Companies Like Neurogene (NASDAQ:NGNE) Are In A Position To Invest In Growth - Nov 26th, 2025 3:51 am
Neurogene: Q3 Earnings Snapshot - Nov 13th, 2025 3:21 pm
Neurogene: Q2 Earnings Snapshot - Aug 11th, 2025 3:55 pm